The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine

NCT05213143 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Company's business decision

Conditions

Schizophrenia

Interventions

DRUG: Lurasidone

Sponsor

Sumitomo Pharma (Suzhou) Co., Ltd.